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Abstract Glucocorticoid receptor (GR) heterozygous
mice (GR
?/2) represent a valuable animal model for major
depression. GR
?/2 mice show a depression-related phe-
notype characterized by increased learned helplessness on
the behavioral level and neuroendocrine alterations with
hypothalamo-pituitary-adrenal (HPA) axis overdrive char-
acteristic of depression. Hippocampal brain-derived neu-
rotrophic factor (BDNF) levels have also been shown to be
reduced in GR
?/2 animals. Because adult hippocampal
neurogenesis has been implicated in the pathophysiology
of affective disorders, we studied here the effects of
the GR
?/2 genotype on neurogenesis in vivo. In a 2 9 2
design, GR
?/2 mice and GR
?/? littermate controls were
either subjected to 1 h of restraint stress or left undisturbed
in their home cages after intraperitoneal injection of BrdU.
Stress exposure and BrdU injections were performed once
daily for 7 days and neurogenesis analyzed 4 weeks later.
BrdU cell counts were signiﬁcantly reduced as an effect of
GR
?/2 genotype and as an effect of stress. Majority of the
BrdU? cells showed co-labeling with mature neuronal
marker NeuN or astrocytic marker S100b with no further
signiﬁcant effect of either experimental condition or of
genotype. In sum, this results in reduced neurogenesis in
GR
?/2 mice which is further repressed by restraint stress.
Our results, thus, reinforce the link between reduced neu-
rogenesis, stress, neurotrophins, and behavioral symptoms
of and susceptibility to depression.
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Introduction
We have recently characterized a strain of glucocorticoid
receptor (GR) heterozygous mice (GR
?/2) in which one GR
allele has been ablated by a conventional knockout strategy,
resulting in an approximately 50% reduction of GR protein
levels in the brain [20]. These animals represent a valuable
model for an endophenotype of severe major depression
characterized by a disinhibited HPA-system due to altered
GR function [11]. Similar to these severely depressed
patients, GR
?/2 mice demonstrate a non-suppression of
corticosterone plasma levels to dexamethasone and a
pathological combined DEX/CRH test. Furthermore, GR
?/
2 mice exhibit an altered neuroendocrine stress response
with increased and prolonged corticosterone release after a
stressor. Behaviorally, GR
?/2 mice show increased learned
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behavior in mice [4, 20].
As a molecular correlate—apart from reduced GR
expression—for this ‘depressive’ phenotype we previ-
ously identiﬁed downregulation of BDNF at the protein
level in hippocampus of GR
?/2 mice [20]. Compromised
adult neurogenesis has also been implicated in the path-
ophysiology of hippocampal aspects of mood disorders
[12]. Importantly, the ‘neurotrophin hypothesis’ of
depression ﬁts well with current concepts emphasizing
the negative impact of stress on hippocampal structure
[7]. Stress robustly impairs progenitor proliferation and
neogenesis of granule neurons in the adult hippocampal
dentate gyrus [5, 8, 9, 17]. Similarly, impaired BDNF
signaling has recently been shown to result in impaired
neurogenesis and refractory responses to antidepressants
[15]. Deletion of the BDNF receptor trkB in adult
progenitors also alters newborn neuron integration into
hippocampal circuits and increases anxiety-like behaviors
[1].
Here, we investigated net hippocampal neurogenesis in
GR
?/2 mice either under control conditions or following
repeated restraint stress. We speculated that neurogenesis
may be compromised in this strain due to its depressive
phenotype and concurrent BDNF downregulation.
Materials and methods
Animals and treatments
The generation of GR-heterozygous mice (GR
?/2) has
been described in detail previously [20]. Brieﬂy, the
founders of GR
?/2 mice were developed by using
homologous recombination in embryonic stem cells as
described earlier [23]. GR
?/2 mice were generated by
crossing heterozygous C57BL/6N males (backcrossed for
[10 generations) with wild-type FVB/N females in order
to obtain F1 hybrid mice with exactly the same background
as previously used for behavioral and neurochemical
characterization studies [20].
Fig. 1 Experimental paradigm:
description of experimental
procedures is given in
‘‘Materials and methods’’.
N = 9–10 animals per group
and condition
Fig. 2 Quantitative assessment of net neurogenesis. a The number of
BrdU? cells was analyzed 4 weeks after a 7-day series of once-daily
BrdU injections. Two-way ANOVA yielded a signiﬁcant effect
of factor ‘treatment condition’ (control versus stress condition:
F1,33 = 10.2, p = 0.003) and a signiﬁcant effect of factor genotype
(F1,33 = 4.5, p = 0.04) on BrdU cell counts with no signiﬁcant
interaction between factors (genotype 9 treatment interaction:
F1,33 = 0.8, p = 0.39). *p\0.05 for the effect of stress within
GR
?/2 genotype,
#p\0.05 for the effect of genotype within the
‘stress’ groups. b Phenotypic analysis of BrdU? cells did not reveal
differences in neuronal (NeuN) or astrocytic (S100b) marker
expression among experimental groups
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?/2 mice and wild-type littermate controls
were 4–6 months old at the beginning of experiments.
Mice were housed individually in standard laboratory
cages under a reversed 12 h:12 h light/dark cycle, with
ad libitum access to food and water. All experiments were
performed according to national and institutional guide-
lines and were approved by German animal welfare
authorities. Thymidine analog BrdU (5-Bromo-20-deoxy-
uridine; Sigma-Aldrich, Germany) was administered
intraperitoneally at a concentration of 50 mg/kg body
weight once daily. Restraint stress consisted of placing a
mouse inside a plastic tube (inner diameter: 26 mm) for 1 h
during the dark phase.
The experiment was structured in a 2 9 2 design
(Fig. 1). Brieﬂy, all animals received daily BrdU injections
for a period of 7 days. Additionally, two groups were
subjected to 1 h of restraint stress after BrdU injections. All
animals were killed after an interval of 4 weeks. All
experiments were performed according to the ‘Principles of
laboratory animal care’ (NIH publication No. 86-23,
revised 1985) and conformed to national and institutional
guidelines.
Immunohistochemistry
Mice were deeply anesthetized with ketamine and tran-
scardially perfused with 0.9% sodium chloride followed by
4% paraformaldehyde (PFA) in 0.1 M phosphate buffer.
Brains were dissected from the skulls, postﬁxed in 4% PFA
at 4 C over night, and transferred into 30% sucrose for
dehydration. Brains were cut on a sliding microtome (Le-
ica, Bensheim, Germany) in the coronal plane in 40-lm-
thick sections and cryoprotected. Sections were stained free
ﬂoating with all antibodies diluted in Tris-buffered saline
containing 3% donkey serum and 0.1% Triton X-100. For
BrdU staining, DNA was denatured in 2 N HCl for 30 min
at 37 C. Sections were then rinsed in 0.1 M borate buffer
and washed in Tris-buffered saline (TBS). Primary and
secondary antibodies were diluted in TBS containing 0.1%
Triton X-100 and 3% donkey serum (TBS?). Primary
antibodies were applied in the following concentrations:
anti-BrdU (rat, 1:500; Harlan Seralab, Indianapolis, IN),
anti-NeuN (mouse, 1:100; Chemicon, Temecula, CA), anti-
S100b (rabbit, 1:2500; Swant, Bellinzona, Switzerland).
Immunohistochemistry followed the peroxidase method
with biotinylated secondary antibody (Jackson Immuno-
Research Laboratories, West Grove, PA), ABC Elite
reagent (Vector Laboratories, Burlingame, CA) and diam-
inobenzidine (DAB; Sigma) as chromogen. For immuno-
ﬂuorescence FITC-, RhodRedX- or Cy5-conjugated
secondary antibodies were all used at a concentration of
1:250. Fluorescent sections were coverslipped in polyvinyl
alcohol with diazabicyclooctane (DABCO) as an anti-fad-
ing agent.
Quantiﬁcation and imaging
Cell counts were determined in one-in-six series of
sections covering the entire hippocampus in its rostro-
caudal extension as described previously [13, 14].
Brieﬂy, cells located in the granule cell layer and adja-
cent subgranular zone, deﬁned as a two-cell body-wide
zone of the hilus along the base of the granule cell layer
were counted [2]. Cells in the uppermost focal plane
were excluded to avoid oversampling. Phenotypic anal-
ysis of BrdU-labeled cells was performed using a spec-
tral confocal microscope (TCS SP2; Leica, Nussloch,
Germany). Appropriate gain and black level settings
were determined on control slices stained with secondary
antibodies alone.
Fig. 3 BrdU? cells in the
dentate gyrus are reduced as an
effect of GR
?/- genotype and as
an effect of stress. The four
images show BrdU-stained cells
(DAB) in representative
hippocampal sections of
animals from the respective
experimental groups. a GR
?/?
mice in the control condition.
b GR
?/? mice in the stress
condition. c GR
?/2 mice in the
control condition. d GR
?/2
mice in the stress condition
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All numerical analyses were performed using Statview
5.0.1. for Macintosh. Two-way ANOVA was followed
by Fisher’s post hoc test, where appropriate. All values
are given as mean ± standard error of the mean (SEM).
P-values of\0.05 were considered statistically signiﬁcant.
Results
Net neurogenesis in the hippocampus was analyzed
4 weeks after a 7-day course of single daily intraperitoneal
injections of BrdU. In this particular injection paradigm,
BrdU counts reﬂect a combination of initial proliferation
and subsequent survival of newly generated cells. The
experimental set-up is illustrated in Fig. 1. Brieﬂy, GR
?/2
mice and GR
?/? littermate controls were subjected either
to the control condition (undisturbed in home cage) or to
the stress condition (1 h of restraint stress directly after
intraperitoneal injection of BrdU).
Two-way ANOVA revealed that BrdU cell counts were
signiﬁcantly reduced as an effect of stress and as an effect
of GR
?/2 genotype (detailed results of the ANOVA sta-
tistics are presented in Figs. 2a and 3; analysis of 37 ani-
mals in total, n = 9–10 animals/group). BrdU-labeled cells
were subjected to further phenotypic analysis. The majority
of cells showed co-labeling with mature neuronal marker
NeuN or astrocytic marker S100b (Figs. 2b and 4) with no
further signiﬁcant effect of either experimental condition or
of genotype.
Discussion
Here we show that depression-prone GR
?/2 mice exhibit a
signiﬁcant net reduction of adult hippocampal neurogene-
sis. GR
?/2 mice represent a particularly valuable animal
model of depression because they reﬂect HPA system
dysregulation which is a hallmark of a subgroup of
depressive disorders in humans [3]. Our observation is in
line with the concept that neurogenesis has a role in the
etiopathogenesis of mood disorders and contributes to the
therapeutic actions of antidepressants [6, 16, 22]; but see
also [10, 19, 24].
A number of current studies have provided novel
insights into the link between depression-related behaviors
and altered neurogenesis. In particular, recent work has
shown that ‘learned safety’, as opposed to learned help-
lessness is associated with increased survival of new neu-
rons and increased BDNF levels in hippocampus and that
Fig. 4 Phenotypic analysis a Confocal image of a newly generated
astrocyte in the granule cell layer expressing mature astrocytic marker
S100b (blue) and BrdU (red). Emission intensities measured along
the lines drawn in the larger image (a) are shown in the bottom and
right panels. Furthermore, insets in a show the cell investigated in
single channels with separate wavelengths. b Newly generated neuron
labeled with BrdU (red) and expressing NeuN-immunoreactivity
(green). c BrdU-positive cell (red) expressing neither neuronal
marker NeuN (green) nor astrocytic marker S100b (blue). Scale bars
in a, b, and c 25 lm
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learning [18]. Several other recent studies also demon-
strate a link between BDNF signaling, neurogenesis, and
behavior [1, 15, 21]. In particular, ablation of BDNF
receptor trkB in neural precursor cells results in impaired
neurogenesis. When exposed to chronic antidepressant
treatment or wheel-running, no increase in neurogenesis
h a sb e e no b s e r v e di nt h e s em i c e[ 15]. Furthermore,
ablation of trkB also renders the animals behaviorally
insensitive to antidepressive treatment in depression- and
anxiety-like paradigms [15]. Lack of trkB in adult pro-
genitors also results in disturbed organization of basic
synaptic connections of newly generated neurons and
impaired neurogenesis-dependent long-term potentiation,
accompanied by compromised survival of newly gener-
ated cells and increased anxiety-like behaviors [1].
Reduced net hippocampal neurogenesis in GR
?/2 mice as
reported here ﬁts well with these reports. Importantly, we
have previously demonstrated a signiﬁcant reduction of
BDNF protein concentrations in hippocampus of GR
?/2
mice [20]. However, it should be noted that the reduction
in neurogenesis in GR
?/2 mice which emerged in this
comparatively large experiment was only moderate. This
may support the notion that in addition to reduced neu-
rogenesis, other mechanisms may also contribute promi-
nently to the depression-related behavioral phenotype of
GR
?/2 mice [6].
In summary, we here demonstrate reduced net adult
hippocampal neurogenesis in GR
?/2 mice, a novel genetic
mouse model of affective disorders. Our study provides
further correlative evidence for a link between hippocam-
pal neurogenesis, glucocorticoids, BDNF, and depression.
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